What diagnostic tests are appropriate for evaluating a patient with suspected serotonin syndrome?

Diagnostic Testing for Serotonin Syndrome

Serotonin syndrome is a clinical diagnosis with no pathognomonic laboratory or radiographic findings—testing serves to exclude alternative diagnoses, assess complications, and guide supportive care, not to confirm the diagnosis. 1

Primary Diagnostic Approach

The diagnosis relies on clinical criteria (Hunter criteria preferred) combined with a history of serotonergic drug exposure within the past 5 weeks. Laboratory and imaging studies are obtained based on clinical suspicion to rule out mimics and detect complications, not to establish the diagnosis itself. 1

Recommended Laboratory Tests

When serotonin syndrome is suspected, obtain the following tests to assess for complications and exclude alternative diagnoses 1:

Core Laboratory Panel

• Complete blood cell count (CBC) - may show leukocytosis in severe cases
• Comprehensive metabolic panel including:
  • Electrolytes (sodium, potassium, chloride, bicarbonate)
  • Serum urea nitrogen (BUN) and creatinine - to assess for renal failure
  • Hepatic transaminases (AST, ALT) - elevated in severe cases with liver dysfunction
• Creatine kinase (CK) - markedly elevated in severe cases with rhabdomyolysis
• Arterial blood gas (ABG) - to check respiratory status and detect metabolic acidosis

Additional Testing Based on Severity

• Urinalysis - to assess for myoglobinuria from rhabdomyolysis
• Coagulation studies (PT/INR, PTT) - if disseminated intravascular coagulopathy suspected in severe cases
• Toxicology screens (serum and urine) - to identify causative agents and rule out co-ingestions

Cardiac and Neurological Studies

• Electrocardiography (ECG) - to detect arrhythmias and assess for QT prolongation from serotonergic agents 1
• Electroencephalography (EEG) - may be considered if seizures are suspected or to support diagnosis in unclear cases 1, 2
• Brain imaging (CT or MRI) - only if alternative diagnoses (meningitis, encephalitis, intracranial hemorrhage, stroke) cannot be excluded clinically 1

Critical Pitfalls to Avoid

Do not wait for laboratory confirmation before initiating treatment. The mortality rate is approximately 11%, and severe cases progress rapidly to life-threatening complications including hyperthermia >41.1°C, seizures, and multiorgan failure. 1

Key complications to monitor for in severe cases 1:

• Rhabdomyolysis (elevated CK, myoglobinuria)
• Metabolic acidosis (low pH, low bicarbonate on ABG)
• Acute kidney injury (elevated creatinine)
• Hepatic dysfunction (elevated transaminases)
• Disseminated intravascular coagulopathy (abnormal PT/PTT, low platelets, elevated D-dimer)
• Seizures

Differential Diagnosis Testing

Testing must distinguish serotonin syndrome from other drug toxicity syndromes 1:

• Neuroleptic malignant syndrome (NMS) - similar presentation but "lead pipe" rigidity rather than hyperreflexia/clonus; history of dopamine antagonist exposure
• Malignant hyperthermia - requires anesthesia exposure (halothane, succinylcholine); family history may be present
• Anticholinergic poisoning - dry mucous membranes, absent bowel sounds, hyporeflexia (opposite of serotonin syndrome)
• CNS infections - lumbar puncture if meningitis/encephalitis cannot be excluded clinically

Clinical Diagnostic Criteria

While not a "test," applying Hunter Criteria is essential 1:

In the presence of a serotonergic agent, serotonin syndrome is diagnosed if ANY of the following are present:

• Spontaneous clonus
• Inducible clonus + (agitation OR diaphoresis)
• Ocular clonus + (agitation OR diaphoresis)
• Tremor + hyperreflexia
• Hypertonia + temperature >38°C + (ocular clonus OR inducible clonus)

The most diagnostically valuable physical findings are clonus and hyperreflexia, which are highly specific when present with serotonergic drug exposure. 1